The results indicated that the NF-κB signaling pathway, which was demonstrated to be dysregulated and functional in the ROS-related chemotherapeutic resistance of ccRCC cells [24, 25], might intervene in the regulation of G6PD expression. This evidence concerns the gene NFKB1 and nonpapillary renal cell carcinoma.